The recent study of Reports and Data on the suggests that the Neurodiagnostics market will be valued at USD 27.10 billion, growing at a CAGR of 7.8%. The study involves the analysis of the market for Neurodiagnostics, which consists of a series of diagnostic tests and medical procedures conducted to identify the malfunctions of the central nervous system. It involves the monitoring and analysis of the nervous system, which will enable the efficient initiation of treatment procedures. The simple blockage of the pathway of neuron flow can lead to the emergence of complex neurological disorders like Parkinson’s and Multiple Sclerosis. The mental illness can be responsible for about 33% of a person’s lived disability and leads to the reduction of the quality of life. The market is characterized by the adoption of novel technologies beginning from imaging technologies to the discovery of digital biomarkers, which has helped to combat the global burdens of mental and neurological disorders.
The growth trajectory of the Neurodiagnostics market has taken a progressive path, primarily due to the prevalence of neurological disorders among people in this contemporary era. The adoption of innovative technology for enhancing the efficiency of diagnosis, which will ease the treatment procedure has also augmented the market to a higher level. The government initiatives to grapple against the prevalence of neurological disorders and improvement in general awareness among people has made the market a favorable floor to channelize investments. Key players are engaged in various industrial strategies such as competitive landscape, and the merger and acquisition strategies are expected to increase the market growth. However, regulations from notifying authorities like FDA and high procedural costs have dimmed the market to an extent.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2236
This study aims to define market sizes and forecast the values for different segments and countries in the coming eight years. The study aims to include qualitative and quantitative perspectives about the industry within the regions and countries covered in the report. The report also outlines the significant factors, such as driving factors and challenges, that will determine the market’s future growth.
Further Key Findings from the report:
- Various technological advancements are being adopted by the various key players. For example, in 2017 Carnegie Mellon University engineers and cognitive neuroscientists have launched the first non-invasive, higher resolution next generation brain-interface technology. Increasing demand for non-invasive treatments is expected to boost the market growth of Neurodiagnostic market
- Various players are involved in various strategic initiatives to expand the client reach of the field players. For instance, MediXall Group Inc. has entered into a new partnership with CoreChoice, Inc., this has provided MediXall access to the series of radiology product line of CoreChoice.
- It was found that neuroimaging was the most prominent segment among the technologies used in the diagnosis. This can be attributed to the varieties of modalities used for diagnosis
- Real-time data is required by the end users in order to complete the effective diagnosis of neurological disorders. The key players are catering to these dynamic needs. For instance, Nihon Kohden launched its airEEG WEE-1200 wireless system which helped in the continuous and comprehensive term monitoring of diseases like Epilepsy
- Asia-Pacific regional segment of the Neurodiagnostics market is expected to be the fastest growing segment with a CAGR of 9.1%. This can be attributed to the increasing population and even the life expectancy in countries like India and China
- In the neuro imaging segment, the Computerized Tomography scan accounted the largest share as it is a non-invasive procedure which helps in the accurate detection of tumors and other abnormalities
- Among the end user, hospitals and clinics accounted for the largest share of about 69.8%. This can be attributed to the availability of advanced technology guiding the diagnosis procedures and ease of getting reimbursements and coverage
- Owing to the demand for MRI imaging, top players strived to bring in advanced solutions to in the medical practitioners globally. For instance, Clariscan, a contrast agent based on Gadolinium was designed by GE health care to effectively aid the visualization needs
- Among the key competitor strategies, product launch was identified as the primary strategy to capitalize the market shares
- Biomarkers and Artificial intelligence for predictive analysis were recognized as key emerging trends in the market. For instance, Thermo Fischer Scientific developed the TAU protein ELISA kit for the diagnosis of Alzheimer’s. However, it has not yet been used for commercial purposes. But has been excessively used for clinical research programs
Competitive Landscape:
The report also focuses on details of each market player including its global position, financial standing, revenue generation, company overview, and product & service portfolio. The Neurodiagnostics market is extremely competitive and consists of several key players at the regional and global levels. Key players are focused on adopting various strategies such as new product launches, mergers and acquisitions, investments in R&D, partnerships, joint ventures, and collaborations to strengthen their market position and enhance their product portfolio.
Leading companies operating in the market are:
GE Healthcare, Siemens Healthineers, Philips Healthcare, Canon Medical Systems Corporation, Hitachi Medical Corporation, Nihon Kohden Corporation, Fonar Corporation, Neusoft Medical Systems Co., Ltd. NeuroNexus Technologies, Inc. and Lifelines Neurodiagnostic Systems, Inc
Inquiry Before Buying @ https://www.reportsanddata.com/inquiry-before-buying/2236
The report also offers detailed insights about market segmentation based on type, application and regional bifurcation:
Neurodiagnostics Market Segmentation:
Technology Type (Revenue, USD Million; 2017–2027)
- Neuroimaging Technology
- Computed Tomography
- Magnetic Resonance Imaging
- Nuclear Medicine Imaging
- Near Infrared Spectroscopic Imaging
- Electroencephalography
- Magnetoencephalography
- Voxel-Based Morphometry
- In Vitro Diagnosis
- Neuroinformatics
Disease Type (Revenue, USD Million; 2017–2027)
- Alzheimer’s Disease
- Migraine
- Parkinson’s Disease
- Epilepsy
- Stroke
- Multiple sclerosis
- Neurodegeneration
- Others
End Use (Revenue, USD Million; 2017–2027)
- Hospital and Clinics
- Diagnostic Laboratories
- Others
Regional Outlook:
- North America (U.S., Canada, Mexico)
- Europe (Germany, U.K., Italy, France, BENELUX, Rest of Europe)
- Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
- Latin America (Brazil, Rest of LATAM)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of the Middle East & Africa)
Some essential purposes of the Neurodiagnostics market research report:
- Vital Developments: Custom investigation provides critical improvements to the Neurodiagnostics market, including R&D, new item shipment, coordinated efforts, development rate, partnerships, joint efforts, and local development of rivals working in the market on a global scale and regional.
- Market Characteristics: The report contains Neurodiagnostics market highlights, income, limit, limit utilization rate, value, net, creation rate, generation, utilization, import, trade, supply, demand, cost, part of the industry in general, CAGR, and gross margin. Likewise, the market report offers an exhaustive investigation of the elements and their most recent patterns, along with Service market fragments and subsections.
- Investigative Tools: This market report incorporates the accurately considered and evaluated information of the major established players and their extension into the Neurodiagnostics market by methods. Systematic tools and methodologies, for example, Porter’s Five Powers Investigation, Possibilities Study, and numerous other statistical investigation methods have been used to analyze the development of the key players working in the Neurodiagnostics market.
- Convincingly, the Neurodiagnostics report will give you an unmistakable perspective on every single market reality without the need to allude to some other research report or source of information. This report will provide all of you with the realities about the past, present, and eventual fate of the Neurodiagnostics market.
Request customization of the report @ https://www.reportsanddata.com/request-customization-form/2236
Thank you for reading the report. Kindly note that we also offer customized reports according to the client’s requirements. Contact us to know more about the customization feature and our team will provide you with the best-customized report.
Explore More Industry Research by Reports and Data:
Diagnostic Biomarkers Market @ https://www.biospace.com/article/diagnostic-biomarkers-market-growth-2027-advancements-in-laboratory-techniques-and-expansion-of-the-molecular-biology-sector/
Cervical Dysplasia Market @ https://www.biospace.com/article/cervical-dysplasia-market-growth-2022-2028-rising-prevalence-of-cancer-in-women-across-the-globe-is-drive-growth-of-industry/
Proteomics Market @ https://www.biospace.com/article/proteomics-market-growth-2022-2028-rising-trend-of-personalized-medicine-is-key-factor-driving-growth-of-the-market/
Antiviral Drugs Market @ https://www.biospace.com/article/antiviral-drugs-market-growth-2022-2030-rising-incidence-of-influenza-respiratory-syncytial-virus-activity-and-other-viral-respiratory-infections/
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, TouchPoints, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provide our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: [email protected]
LinkedIn | Twitter | Blogs
Read the innovative blog at https://www.reportsanddata.com/blogs
Check out our upcoming research report at https://www.reportsanddata.com/upcoming-reports
For More Research Insights on Leading Industries, Visit Our YouTube Channel and hit subscribe for Future Update: https://www.youtube.com/channel/UChLqKTFLm6sVBLEUjnadIhQ/videos